nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—CYP2C18—malignant glioma	0.273	0.448	CbGaD
Valproic Acid—CYP2B6—malignant glioma	0.203	0.333	CbGaD
Valproic Acid—PTGS1—malignant glioma	0.133	0.219	CbGaD
Valproic Acid—CYP1A2—Carmustine—malignant glioma	0.0346	0.57	CbGbCtD
Valproic Acid—CYP3A4—Temozolomide—malignant glioma	0.0262	0.431	CbGbCtD
Valproic Acid—SLC22A8—choroid plexus—malignant glioma	0.00745	0.124	CbGeAlD
Valproic Acid—Behavior disorder—Temozolomide—malignant glioma	0.00625	0.0515	CcSEcCtD
Valproic Acid—Myelodysplastic syndrome—Temozolomide—malignant glioma	0.00359	0.0296	CcSEcCtD
Valproic Acid—Teratogenicity—Carmustine—malignant glioma	0.00356	0.0293	CcSEcCtD
Valproic Acid—HDAC2—telencephalic ventricle—malignant glioma	0.00325	0.0542	CbGeAlD
Valproic Acid—Abnormal behaviour—Temozolomide—malignant glioma	0.00193	0.0159	CcSEcCtD
Valproic Acid—Traumatic liver injury—Temozolomide—malignant glioma	0.00193	0.0159	CcSEcCtD
Valproic Acid—OGDH—retina—malignant glioma	0.00188	0.0314	CbGeAlD
Valproic Acid—OGDH—telencephalon—malignant glioma	0.00173	0.0289	CbGeAlD
Valproic Acid—Personality disorder—Carmustine—malignant glioma	0.00172	0.0142	CcSEcCtD
Valproic Acid—HDAC9—telencephalon—malignant glioma	0.00153	0.0254	CbGeAlD
Valproic Acid—Faecal incontinence—Carmustine—malignant glioma	0.00148	0.0122	CcSEcCtD
Valproic Acid—Faecal incontinence—Temozolomide—malignant glioma	0.00143	0.0118	CcSEcCtD
Valproic Acid—ALDH5A1—brainstem—malignant glioma	0.00136	0.0227	CbGeAlD
Valproic Acid—OGDH—medulla oblongata—malignant glioma	0.00136	0.0227	CbGeAlD
Valproic Acid—OGDH—spinal cord—malignant glioma	0.00121	0.0202	CbGeAlD
Valproic Acid—ALDH5A1—telencephalon—malignant glioma	0.00121	0.0202	CbGeAlD
Valproic Acid—Myasthenia—Carmustine—malignant glioma	0.00119	0.00977	CcSEcCtD
Valproic Acid—ABAT—brainstem—malignant glioma	0.00117	0.0195	CbGeAlD
Valproic Acid—Encephalopathy—Carmustine—malignant glioma	0.00116	0.00956	CcSEcCtD
Valproic Acid—ABAT—retina—malignant glioma	0.00113	0.0188	CbGeAlD
Valproic Acid—Cyst—Carmustine—malignant glioma	0.00112	0.00918	CcSEcCtD
Valproic Acid—Tooth disorder—Temozolomide—malignant glioma	0.00111	0.00915	CcSEcCtD
Valproic Acid—Hypokinesia—Carmustine—malignant glioma	0.0011	0.00909	CcSEcCtD
Valproic Acid—HDAC9—midbrain—malignant glioma	0.0011	0.0183	CbGeAlD
Valproic Acid—ACADSB—medulla oblongata—malignant glioma	0.00108	0.018	CbGeAlD
Valproic Acid—ABAT—telencephalon—malignant glioma	0.00104	0.0173	CbGeAlD
Valproic Acid—Influenza-like symptoms—Temozolomide—malignant glioma	0.00101	0.0083	CcSEcCtD
Valproic Acid—Stupor—Carmustine—malignant glioma	0.000999	0.00822	CcSEcCtD
Valproic Acid—ACADSB—midbrain—malignant glioma	0.000988	0.0165	CbGeAlD
Valproic Acid—OGDH—central nervous system—malignant glioma	0.000984	0.0164	CbGeAlD
Valproic Acid—Vaginal haemorrhage—Temozolomide—malignant glioma	0.000973	0.00801	CcSEcCtD
Valproic Acid—Hepatotoxicity—Carmustine—malignant glioma	0.000965	0.00795	CcSEcCtD
Valproic Acid—ACADSB—spinal cord—malignant glioma	0.000964	0.0161	CbGeAlD
Valproic Acid—OGDH—cerebellum—malignant glioma	0.000962	0.016	CbGeAlD
Valproic Acid—HDAC2—embryo—malignant glioma	0.000959	0.016	CbGeAlD
Valproic Acid—Extrapyramidal disorder—Temozolomide—malignant glioma	0.000957	0.00788	CcSEcCtD
Valproic Acid—ALDH5A1—medulla oblongata—malignant glioma	0.000951	0.0159	CbGeAlD
Valproic Acid—Necrosis—Carmustine—malignant glioma	0.00095	0.00782	CcSEcCtD
Valproic Acid—Hepatotoxicity—Temozolomide—malignant glioma	0.000933	0.00768	CcSEcCtD
Valproic Acid—Otitis media—Temozolomide—malignant glioma	0.000925	0.00762	CcSEcCtD
Valproic Acid—Coagulopathy—Temozolomide—malignant glioma	0.000925	0.00762	CcSEcCtD
Valproic Acid—Memory impairment—Temozolomide—malignant glioma	0.000918	0.00756	CcSEcCtD
Valproic Acid—Injection site pain—Carmustine—malignant glioma	0.000913	0.00752	CcSEcCtD
Valproic Acid—HDAC2—brainstem—malignant glioma	0.000879	0.0147	CbGeAlD
Valproic Acid—Petechiae—Temozolomide—malignant glioma	0.000876	0.00721	CcSEcCtD
Valproic Acid—ALDH5A1—midbrain—malignant glioma	0.00087	0.0145	CbGeAlD
Valproic Acid—Endocrine disorder—Temozolomide—malignant glioma	0.000869	0.00716	CcSEcCtD
Valproic Acid—HDAC9—central nervous system—malignant glioma	0.000868	0.0145	CbGeAlD
Valproic Acid—Speech disorder—Carmustine—malignant glioma	0.000867	0.00714	CcSEcCtD
Valproic Acid—Liver injury—Temozolomide—malignant glioma	0.000856	0.00705	CcSEcCtD
Valproic Acid—ALDH5A1—spinal cord—malignant glioma	0.000848	0.0141	CbGeAlD
Valproic Acid—HDAC2—retina—malignant glioma	0.000848	0.0141	CbGeAlD
Valproic Acid—HDAC9—cerebellum—malignant glioma	0.000848	0.0141	CbGeAlD
Valproic Acid—Accidental injury—Carmustine—malignant glioma	0.000843	0.00694	CcSEcCtD
Valproic Acid—Speech disorder—Temozolomide—malignant glioma	0.000838	0.0069	CcSEcCtD
Valproic Acid—Disturbance in attention—Temozolomide—malignant glioma	0.000832	0.00685	CcSEcCtD
Valproic Acid—Amenorrhoea—Temozolomide—malignant glioma	0.00082	0.00675	CcSEcCtD
Valproic Acid—Thinking abnormal—Carmustine—malignant glioma	0.000814	0.00671	CcSEcCtD
Valproic Acid—ABAT—medulla oblongata—malignant glioma	0.000814	0.0136	CbGeAlD
Valproic Acid—Drug interaction—Carmustine—malignant glioma	0.000804	0.00662	CcSEcCtD
Valproic Acid—Viral infection—Temozolomide—malignant glioma	0.000798	0.00657	CcSEcCtD
Valproic Acid—OGDH—brain—malignant glioma	0.000781	0.013	CbGeAlD
Valproic Acid—HDAC2—telencephalon—malignant glioma	0.00078	0.013	CbGeAlD
Valproic Acid—ACADSB—cerebellum—malignant glioma	0.000764	0.0127	CbGeAlD
Valproic Acid—Gait disturbance—Carmustine—malignant glioma	0.000764	0.00629	CcSEcCtD
Valproic Acid—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000762	0.00627	CcSEcCtD
Valproic Acid—Coordination abnormal—Carmustine—malignant glioma	0.000759	0.00625	CcSEcCtD
Valproic Acid—Hearing impaired—Temozolomide—malignant glioma	0.000757	0.00623	CcSEcCtD
Valproic Acid—Neck pain—Carmustine—malignant glioma	0.000755	0.00621	CcSEcCtD
Valproic Acid—SLC16A1—retina—malignant glioma	0.000754	0.0126	CbGeAlD
Valproic Acid—ABAT—midbrain—malignant glioma	0.000744	0.0124	CbGeAlD
Valproic Acid—Injection site reaction—Carmustine—malignant glioma	0.000741	0.0061	CcSEcCtD
Valproic Acid—Gait disturbance—Temozolomide—malignant glioma	0.000738	0.00608	CcSEcCtD
Valproic Acid—Coordination abnormal—Temozolomide—malignant glioma	0.000734	0.00604	CcSEcCtD
Valproic Acid—ABAT—spinal cord—malignant glioma	0.000726	0.0121	CbGeAlD
Valproic Acid—Vaginal inflammation—Temozolomide—malignant glioma	0.00072	0.00593	CcSEcCtD
Valproic Acid—Depressed level of consciousness—Carmustine—malignant glioma	0.00072	0.00593	CcSEcCtD
Valproic Acid—Urinary incontinence—Carmustine—malignant glioma	0.00072	0.00593	CcSEcCtD
Valproic Acid—Influenza like illness—Temozolomide—malignant glioma	0.0007	0.00576	CcSEcCtD
Valproic Acid—Depressed level of consciousness—Temozolomide—malignant glioma	0.000696	0.00573	CcSEcCtD
Valproic Acid—Urinary incontinence—Temozolomide—malignant glioma	0.000696	0.00573	CcSEcCtD
Valproic Acid—PTGS1—endothelium—malignant glioma	0.000695	0.0116	CbGeAlD
Valproic Acid—SLC16A1—telencephalon—malignant glioma	0.000693	0.0116	CbGeAlD
Valproic Acid—HDAC9—brain—malignant glioma	0.000689	0.0115	CbGeAlD
Valproic Acid—ALDH5A1—central nervous system—malignant glioma	0.000688	0.0115	CbGeAlD
Valproic Acid—Coma—Carmustine—malignant glioma	0.000681	0.00561	CcSEcCtD
Valproic Acid—Vaginal infection—Temozolomide—malignant glioma	0.00068	0.0056	CcSEcCtD
Valproic Acid—Aplastic anaemia—Temozolomide—malignant glioma	0.000676	0.00557	CcSEcCtD
Valproic Acid—Neoplasm—Carmustine—malignant glioma	0.000674	0.00555	CcSEcCtD
Valproic Acid—ALDH5A1—cerebellum—malignant glioma	0.000673	0.0112	CbGeAlD
Valproic Acid—Dry eye—Temozolomide—malignant glioma	0.000665	0.00548	CcSEcCtD
Valproic Acid—Neoplasm—Temozolomide—malignant glioma	0.000651	0.00536	CcSEcCtD
Valproic Acid—Abnormal vision—Carmustine—malignant glioma	0.00065	0.00535	CcSEcCtD
Valproic Acid—Mental disability—Carmustine—malignant glioma	0.000647	0.00533	CcSEcCtD
Valproic Acid—PTGS1—blood vessel—malignant glioma	0.000641	0.0107	CbGeAlD
Valproic Acid—Abnormal vision—Temozolomide—malignant glioma	0.000628	0.00517	CcSEcCtD
Valproic Acid—Mental disability—Temozolomide—malignant glioma	0.000625	0.00515	CcSEcCtD
Valproic Acid—ACADSB—brain—malignant glioma	0.000621	0.0103	CbGeAlD
Valproic Acid—Swelling—Carmustine—malignant glioma	0.000613	0.00505	CcSEcCtD
Valproic Acid—HDAC2—medulla oblongata—malignant glioma	0.000613	0.0102	CbGeAlD
Valproic Acid—Ear pain—Temozolomide—malignant glioma	0.000613	0.00505	CcSEcCtD
Valproic Acid—Eye pain—Carmustine—malignant glioma	0.000599	0.00494	CcSEcCtD
Valproic Acid—Gastroenteritis—Temozolomide—malignant glioma	0.00059	0.00486	CcSEcCtD
Valproic Acid—Injury—Carmustine—malignant glioma	0.000589	0.00485	CcSEcCtD
Valproic Acid—ABAT—central nervous system—malignant glioma	0.000589	0.00982	CbGeAlD
Valproic Acid—Deafness—Temozolomide—malignant glioma	0.000585	0.00481	CcSEcCtD
Valproic Acid—Hepatic failure—Temozolomide—malignant glioma	0.000582	0.00479	CcSEcCtD
Valproic Acid—Eye pain—Temozolomide—malignant glioma	0.000579	0.00477	CcSEcCtD
Valproic Acid—Amnesia—Carmustine—malignant glioma	0.000576	0.00474	CcSEcCtD
Valproic Acid—ABAT—cerebellum—malignant glioma	0.000575	0.0096	CbGeAlD
Valproic Acid—HDAC2—midbrain—malignant glioma	0.00056	0.00934	CbGeAlD
Valproic Acid—Amnesia—Temozolomide—malignant glioma	0.000557	0.00458	CcSEcCtD
Valproic Acid—ALDH5A1—brain—malignant glioma	0.000546	0.00911	CbGeAlD
Valproic Acid—SLC16A1—medulla oblongata—malignant glioma	0.000545	0.00908	CbGeAlD
Valproic Acid—Hyponatraemia—Carmustine—malignant glioma	0.000543	0.00447	CcSEcCtD
Valproic Acid—Diplopia—Carmustine—malignant glioma	0.000541	0.00446	CcSEcCtD
Valproic Acid—Diplopia—Temozolomide—malignant glioma	0.000523	0.00431	CcSEcCtD
Valproic Acid—Face oedema—Carmustine—malignant glioma	0.000522	0.0043	CcSEcCtD
Valproic Acid—Affect lability—Temozolomide—malignant glioma	0.000515	0.00424	CcSEcCtD
Valproic Acid—Ataxia—Carmustine—malignant glioma	0.000509	0.00419	CcSEcCtD
Valproic Acid—Face oedema—Temozolomide—malignant glioma	0.000505	0.00416	CcSEcCtD
Valproic Acid—SLC16A1—midbrain—malignant glioma	0.000498	0.0083	CbGeAlD
Valproic Acid—Mood swings—Temozolomide—malignant glioma	0.000495	0.00408	CcSEcCtD
Valproic Acid—Ataxia—Temozolomide—malignant glioma	0.000492	0.00405	CcSEcCtD
Valproic Acid—SLC16A1—spinal cord—malignant glioma	0.000486	0.0081	CbGeAlD
Valproic Acid—Dry skin—Temozolomide—malignant glioma	0.000479	0.00395	CcSEcCtD
Valproic Acid—Muscular weakness—Carmustine—malignant glioma	0.000477	0.00393	CcSEcCtD
Valproic Acid—Breast disorder—Temozolomide—malignant glioma	0.000473	0.00389	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000471	0.00388	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000471	0.00388	CcSEcCtD
Valproic Acid—Dysphagia—Carmustine—malignant glioma	0.000468	0.00385	CcSEcCtD
Valproic Acid—ABAT—brain—malignant glioma	0.000467	0.00779	CbGeAlD
Valproic Acid—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000461	0.0038	CcSEcCtD
Valproic Acid—Muscular weakness—Temozolomide—malignant glioma	0.000461	0.0038	CcSEcCtD
Valproic Acid—Dysphagia—Temozolomide—malignant glioma	0.000452	0.00372	CcSEcCtD
Valproic Acid—Pancytopenia—Carmustine—malignant glioma	0.000444	0.00366	CcSEcCtD
Valproic Acid—HDAC2—central nervous system—malignant glioma	0.000443	0.00739	CbGeAlD
Valproic Acid—Sweating increased—Temozolomide—malignant glioma	0.00044	0.00363	CcSEcCtD
Valproic Acid—Neutropenia—Carmustine—malignant glioma	0.000437	0.0036	CcSEcCtD
Valproic Acid—Bronchitis—Temozolomide—malignant glioma	0.000435	0.00358	CcSEcCtD
Valproic Acid—HDAC2—cerebellum—malignant glioma	0.000433	0.00723	CbGeAlD
Valproic Acid—SLC22A5—retina—malignant glioma	0.000431	0.00718	CbGeAlD
Valproic Acid—Pancytopenia—Temozolomide—malignant glioma	0.000429	0.00353	CcSEcCtD
Valproic Acid—Neutropenia—Temozolomide—malignant glioma	0.000423	0.00348	CcSEcCtD
Valproic Acid—Dysuria—Temozolomide—malignant glioma	0.000423	0.00348	CcSEcCtD
Valproic Acid—Pneumonia—Carmustine—malignant glioma	0.000419	0.00345	CcSEcCtD
Valproic Acid—Pollakiuria—Temozolomide—malignant glioma	0.000418	0.00344	CcSEcCtD
Valproic Acid—Depression—Carmustine—malignant glioma	0.000416	0.00342	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Temozolomide—malignant glioma	0.000413	0.0034	CcSEcCtD
Valproic Acid—Weight increased—Temozolomide—malignant glioma	0.000411	0.00339	CcSEcCtD
Valproic Acid—SLC22A7—brain—malignant glioma	0.000409	0.00682	CbGeAlD
Valproic Acid—Weight decreased—Temozolomide—malignant glioma	0.000409	0.00337	CcSEcCtD
Valproic Acid—Stomatitis—Carmustine—malignant glioma	0.000407	0.00335	CcSEcCtD
Valproic Acid—Urinary tract infection—Carmustine—malignant glioma	0.000405	0.00334	CcSEcCtD
Valproic Acid—Pneumonia—Temozolomide—malignant glioma	0.000405	0.00334	CcSEcCtD
Valproic Acid—Depression—Temozolomide—malignant glioma	0.000402	0.00331	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0004	0.00329	CcSEcCtD
Valproic Acid—SLC22A6—brain—malignant glioma	0.000395	0.00659	CbGeAlD
Valproic Acid—SLC16A1—central nervous system—malignant glioma	0.000394	0.00657	CbGeAlD
Valproic Acid—Stomatitis—Temozolomide—malignant glioma	0.000393	0.00323	CcSEcCtD
Valproic Acid—Urinary tract infection—Temozolomide—malignant glioma	0.000392	0.00323	CcSEcCtD
Valproic Acid—SLC16A1—cerebellum—malignant glioma	0.000385	0.00642	CbGeAlD
Valproic Acid—Hepatobiliary disease—Temozolomide—malignant glioma	0.000381	0.00314	CcSEcCtD
Valproic Acid—CYP2A6—cerebellum—malignant glioma	0.00038	0.00633	CbGeAlD
Valproic Acid—Sinusitis—Temozolomide—malignant glioma	0.000378	0.00311	CcSEcCtD
Valproic Acid—Haemoglobin—Carmustine—malignant glioma	0.000376	0.0031	CcSEcCtD
Valproic Acid—Haemorrhage—Carmustine—malignant glioma	0.000374	0.00308	CcSEcCtD
Valproic Acid—Hallucination—Carmustine—malignant glioma	0.000373	0.00307	CcSEcCtD
Valproic Acid—Hypoaesthesia—Carmustine—malignant glioma	0.000373	0.00307	CcSEcCtD
Valproic Acid—Oedema peripheral—Carmustine—malignant glioma	0.000369	0.00304	CcSEcCtD
Valproic Acid—Connective tissue disorder—Carmustine—malignant glioma	0.000368	0.00303	CcSEcCtD
Valproic Acid—Haemoglobin—Temozolomide—malignant glioma	0.000364	0.00299	CcSEcCtD
Valproic Acid—Haemorrhage—Temozolomide—malignant glioma	0.000362	0.00298	CcSEcCtD
Valproic Acid—Visual impairment—Carmustine—malignant glioma	0.000361	0.00297	CcSEcCtD
Valproic Acid—Hallucination—Temozolomide—malignant glioma	0.00036	0.00296	CcSEcCtD
Valproic Acid—Hypoaesthesia—Temozolomide—malignant glioma	0.00036	0.00296	CcSEcCtD
Valproic Acid—Pharyngitis—Temozolomide—malignant glioma	0.000359	0.00296	CcSEcCtD
Valproic Acid—Urinary tract disorder—Temozolomide—malignant glioma	0.000357	0.00294	CcSEcCtD
Valproic Acid—Oedema peripheral—Temozolomide—malignant glioma	0.000356	0.00293	CcSEcCtD
Valproic Acid—Connective tissue disorder—Temozolomide—malignant glioma	0.000356	0.00293	CcSEcCtD
Valproic Acid—Urethral disorder—Temozolomide—malignant glioma	0.000355	0.00292	CcSEcCtD
Valproic Acid—HDAC2—brain—malignant glioma	0.000352	0.00587	CbGeAlD
Valproic Acid—Eye disorder—Carmustine—malignant glioma	0.00035	0.00288	CcSEcCtD
Valproic Acid—Visual impairment—Temozolomide—malignant glioma	0.000349	0.00287	CcSEcCtD
Valproic Acid—Erythema multiforme—Temozolomide—malignant glioma	0.000342	0.00282	CcSEcCtD
Valproic Acid—Eye disorder—Temozolomide—malignant glioma	0.000338	0.00278	CcSEcCtD
Valproic Acid—Tinnitus—Temozolomide—malignant glioma	0.000337	0.00278	CcSEcCtD
Valproic Acid—Arrhythmia—Carmustine—malignant glioma	0.000334	0.00275	CcSEcCtD
Valproic Acid—Alopecia—Carmustine—malignant glioma	0.000331	0.00272	CcSEcCtD
Valproic Acid—Angiopathy—Temozolomide—malignant glioma	0.000328	0.0027	CcSEcCtD
Valproic Acid—Mental disorder—Carmustine—malignant glioma	0.000328	0.0027	CcSEcCtD
Valproic Acid—Immune system disorder—Temozolomide—malignant glioma	0.000327	0.00269	CcSEcCtD
Valproic Acid—Mediastinal disorder—Temozolomide—malignant glioma	0.000326	0.00268	CcSEcCtD
Valproic Acid—Malnutrition—Carmustine—malignant glioma	0.000326	0.00268	CcSEcCtD
Valproic Acid—Chills—Temozolomide—malignant glioma	0.000325	0.00267	CcSEcCtD
Valproic Acid—Alopecia—Temozolomide—malignant glioma	0.00032	0.00263	CcSEcCtD
Valproic Acid—Mental disorder—Temozolomide—malignant glioma	0.000317	0.00261	CcSEcCtD
Valproic Acid—Back pain—Carmustine—malignant glioma	0.000315	0.0026	CcSEcCtD
Valproic Acid—Malnutrition—Temozolomide—malignant glioma	0.000315	0.00259	CcSEcCtD
Valproic Acid—SLC16A1—brain—malignant glioma	0.000313	0.00522	CbGeAlD
Valproic Acid—SLC22A5—medulla oblongata—malignant glioma	0.000311	0.00519	CbGeAlD
Valproic Acid—PTGS1—telencephalon—malignant glioma	0.000311	0.00519	CbGeAlD
Valproic Acid—Dysgeusia—Temozolomide—malignant glioma	0.000308	0.00254	CcSEcCtD
Valproic Acid—CYP2A6—brain—malignant glioma	0.000308	0.00514	CbGeAlD
Valproic Acid—Vision blurred—Carmustine—malignant glioma	0.000307	0.00253	CcSEcCtD
Valproic Acid—Tremor—Carmustine—malignant glioma	0.000305	0.00251	CcSEcCtD
Valproic Acid—Back pain—Temozolomide—malignant glioma	0.000305	0.00251	CcSEcCtD
Valproic Acid—Anaemia—Carmustine—malignant glioma	0.000301	0.00248	CcSEcCtD
Valproic Acid—Agitation—Carmustine—malignant glioma	0.000299	0.00247	CcSEcCtD
Valproic Acid—SLC22A8—central nervous system—malignant glioma	0.000298	0.00497	CbGeAlD
Valproic Acid—Vision blurred—Temozolomide—malignant glioma	0.000297	0.00244	CcSEcCtD
Valproic Acid—Tremor—Temozolomide—malignant glioma	0.000295	0.00243	CcSEcCtD
Valproic Acid—Ill-defined disorder—Temozolomide—malignant glioma	0.000292	0.00241	CcSEcCtD
Valproic Acid—Leukopenia—Carmustine—malignant glioma	0.000292	0.0024	CcSEcCtD
Valproic Acid—Anaemia—Temozolomide—malignant glioma	0.000291	0.0024	CcSEcCtD
Valproic Acid—Agitation—Temozolomide—malignant glioma	0.000289	0.00238	CcSEcCtD
Valproic Acid—Angioedema—Temozolomide—malignant glioma	0.000288	0.00237	CcSEcCtD
Valproic Acid—SLC22A5—midbrain—malignant glioma	0.000284	0.00474	CbGeAlD
Valproic Acid—Malaise—Temozolomide—malignant glioma	0.000284	0.00234	CcSEcCtD
Valproic Acid—Vertigo—Temozolomide—malignant glioma	0.000283	0.00233	CcSEcCtD
Valproic Acid—Leukopenia—Temozolomide—malignant glioma	0.000282	0.00232	CcSEcCtD
Valproic Acid—Hypertension—Carmustine—malignant glioma	0.000281	0.00232	CcSEcCtD
Valproic Acid—Palpitations—Temozolomide—malignant glioma	0.000278	0.00229	CcSEcCtD
Valproic Acid—SLC22A5—spinal cord—malignant glioma	0.000278	0.00463	CbGeAlD
Valproic Acid—Myalgia—Carmustine—malignant glioma	0.000277	0.00228	CcSEcCtD
Valproic Acid—Chest pain—Carmustine—malignant glioma	0.000277	0.00228	CcSEcCtD
Valproic Acid—Anxiety—Carmustine—malignant glioma	0.000277	0.00228	CcSEcCtD
Valproic Acid—Cough—Temozolomide—malignant glioma	0.000275	0.00226	CcSEcCtD
Valproic Acid—Hypertension—Temozolomide—malignant glioma	0.000272	0.00224	CcSEcCtD
Valproic Acid—Confusional state—Carmustine—malignant glioma	0.000268	0.00221	CcSEcCtD
Valproic Acid—Arthralgia—Temozolomide—malignant glioma	0.000268	0.00221	CcSEcCtD
Valproic Acid—Myalgia—Temozolomide—malignant glioma	0.000268	0.00221	CcSEcCtD
Valproic Acid—Anxiety—Temozolomide—malignant glioma	0.000267	0.0022	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000266	0.00219	CcSEcCtD
Valproic Acid—Oedema—Carmustine—malignant glioma	0.000266	0.00219	CcSEcCtD
Valproic Acid—Discomfort—Temozolomide—malignant glioma	0.000265	0.00218	CcSEcCtD
Valproic Acid—Infection—Carmustine—malignant glioma	0.000264	0.00218	CcSEcCtD
Valproic Acid—Dry mouth—Temozolomide—malignant glioma	0.000262	0.00216	CcSEcCtD
Valproic Acid—Thrombocytopenia—Carmustine—malignant glioma	0.00026	0.00214	CcSEcCtD
Valproic Acid—Tachycardia—Carmustine—malignant glioma	0.00026	0.00214	CcSEcCtD
Valproic Acid—Confusional state—Temozolomide—malignant glioma	0.000259	0.00213	CcSEcCtD
Valproic Acid—Anaphylactic shock—Temozolomide—malignant glioma	0.000257	0.00212	CcSEcCtD
Valproic Acid—Oedema—Temozolomide—malignant glioma	0.000257	0.00212	CcSEcCtD
Valproic Acid—Infection—Temozolomide—malignant glioma	0.000255	0.0021	CcSEcCtD
Valproic Acid—Anorexia—Carmustine—malignant glioma	0.000254	0.00209	CcSEcCtD
Valproic Acid—Nervous system disorder—Temozolomide—malignant glioma	0.000252	0.00208	CcSEcCtD
Valproic Acid—Thrombocytopenia—Temozolomide—malignant glioma	0.000252	0.00207	CcSEcCtD
Valproic Acid—Skin disorder—Temozolomide—malignant glioma	0.00025	0.00206	CcSEcCtD
Valproic Acid—Hypotension—Carmustine—malignant glioma	0.000249	0.00205	CcSEcCtD
Valproic Acid—Hyperhidrosis—Temozolomide—malignant glioma	0.000248	0.00205	CcSEcCtD
Valproic Acid—Anorexia—Temozolomide—malignant glioma	0.000245	0.00202	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000242	0.002	CcSEcCtD
Valproic Acid—Insomnia—Carmustine—malignant glioma	0.000241	0.00198	CcSEcCtD
Valproic Acid—Paraesthesia—Carmustine—malignant glioma	0.000239	0.00197	CcSEcCtD
Valproic Acid—Dyspnoea—Carmustine—malignant glioma	0.000237	0.00195	CcSEcCtD
Valproic Acid—SLC22A8—brain—malignant glioma	0.000236	0.00394	CbGeAlD
Valproic Acid—Somnolence—Carmustine—malignant glioma	0.000236	0.00195	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000234	0.00193	CcSEcCtD
Valproic Acid—Insomnia—Temozolomide—malignant glioma	0.000232	0.00191	CcSEcCtD
Valproic Acid—Decreased appetite—Carmustine—malignant glioma	0.000231	0.0019	CcSEcCtD
Valproic Acid—Paraesthesia—Temozolomide—malignant glioma	0.000231	0.0019	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Carmustine—malignant glioma	0.00023	0.00189	CcSEcCtD
Valproic Acid—Dyspnoea—Temozolomide—malignant glioma	0.000229	0.00189	CcSEcCtD
Valproic Acid—Somnolence—Temozolomide—malignant glioma	0.000229	0.00188	CcSEcCtD
Valproic Acid—Pain—Carmustine—malignant glioma	0.000227	0.00187	CcSEcCtD
Valproic Acid—Constipation—Carmustine—malignant glioma	0.000227	0.00187	CcSEcCtD
Valproic Acid—Dyspepsia—Temozolomide—malignant glioma	0.000226	0.00186	CcSEcCtD
Valproic Acid—Decreased appetite—Temozolomide—malignant glioma	0.000223	0.00184	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000222	0.00183	CcSEcCtD
Valproic Acid—Fatigue—Temozolomide—malignant glioma	0.000222	0.00182	CcSEcCtD
Valproic Acid—SLC22A5—cerebellum—malignant glioma	0.00022	0.00367	CbGeAlD
Valproic Acid—Constipation—Temozolomide—malignant glioma	0.00022	0.00181	CcSEcCtD
Valproic Acid—Pain—Temozolomide—malignant glioma	0.00022	0.00181	CcSEcCtD
Valproic Acid—Feeling abnormal—Carmustine—malignant glioma	0.000219	0.0018	CcSEcCtD
Valproic Acid—PTGS1—spinal cord—malignant glioma	0.000218	0.00363	CbGeAlD
Valproic Acid—Gastrointestinal pain—Carmustine—malignant glioma	0.000218	0.00179	CcSEcCtD
Valproic Acid—Feeling abnormal—Temozolomide—malignant glioma	0.000212	0.00174	CcSEcCtD
Valproic Acid—Abdominal pain—Carmustine—malignant glioma	0.00021	0.00173	CcSEcCtD
Valproic Acid—Body temperature increased—Carmustine—malignant glioma	0.00021	0.00173	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Temozolomide—malignant glioma	0.00021	0.00173	CcSEcCtD
Valproic Acid—Urticaria—Temozolomide—malignant glioma	0.000204	0.00168	CcSEcCtD
Valproic Acid—Body temperature increased—Temozolomide—malignant glioma	0.000203	0.00167	CcSEcCtD
Valproic Acid—Abdominal pain—Temozolomide—malignant glioma	0.000203	0.00167	CcSEcCtD
Valproic Acid—Hypersensitivity—Carmustine—malignant glioma	0.000196	0.00161	CcSEcCtD
Valproic Acid—CYP2B6—central nervous system—malignant glioma	0.000196	0.00326	CbGeAlD
Valproic Acid—Asthenia—Carmustine—malignant glioma	0.000191	0.00157	CcSEcCtD
Valproic Acid—Hypersensitivity—Temozolomide—malignant glioma	0.000189	0.00156	CcSEcCtD
Valproic Acid—Asthenia—Temozolomide—malignant glioma	0.000184	0.00152	CcSEcCtD
Valproic Acid—Diarrhoea—Carmustine—malignant glioma	0.000182	0.0015	CcSEcCtD
Valproic Acid—Pruritus—Temozolomide—malignant glioma	0.000182	0.0015	CcSEcCtD
Valproic Acid—SLC22A5—brain—malignant glioma	0.000179	0.00298	CbGeAlD
Valproic Acid—PTGS1—central nervous system—malignant glioma	0.000177	0.00295	CbGeAlD
Valproic Acid—Dizziness—Carmustine—malignant glioma	0.000176	0.00145	CcSEcCtD
Valproic Acid—Diarrhoea—Temozolomide—malignant glioma	0.000176	0.00145	CcSEcCtD
Valproic Acid—CYP2C8—brain—malignant glioma	0.000173	0.00289	CbGeAlD
Valproic Acid—Dizziness—Temozolomide—malignant glioma	0.00017	0.0014	CcSEcCtD
Valproic Acid—Vomiting—Carmustine—malignant glioma	0.000169	0.00139	CcSEcCtD
Valproic Acid—Rash—Carmustine—malignant glioma	0.000168	0.00138	CcSEcCtD
Valproic Acid—Dermatitis—Carmustine—malignant glioma	0.000168	0.00138	CcSEcCtD
Valproic Acid—Headache—Carmustine—malignant glioma	0.000167	0.00137	CcSEcCtD
Valproic Acid—Vomiting—Temozolomide—malignant glioma	0.000163	0.00135	CcSEcCtD
Valproic Acid—Rash—Temozolomide—malignant glioma	0.000162	0.00133	CcSEcCtD
Valproic Acid—Dermatitis—Temozolomide—malignant glioma	0.000162	0.00133	CcSEcCtD
Valproic Acid—Headache—Temozolomide—malignant glioma	0.000161	0.00133	CcSEcCtD
Valproic Acid—Nausea—Carmustine—malignant glioma	0.000158	0.0013	CcSEcCtD
Valproic Acid—CYP2B6—brain—malignant glioma	0.000155	0.00259	CbGeAlD
Valproic Acid—Nausea—Temozolomide—malignant glioma	0.000153	0.00126	CcSEcCtD
Valproic Acid—CYP3A4—central nervous system—malignant glioma	0.000148	0.00246	CbGeAlD
Valproic Acid—PTGS1—brain—malignant glioma	0.00014	0.00234	CbGeAlD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CG—malignant glioma	5.85e-06	3.92e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.83e-06	3.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—IDH1—malignant glioma	5.82e-06	3.9e-05	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—malignant glioma	5.81e-06	3.9e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—malignant glioma	5.8e-06	3.89e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—IDH2—malignant glioma	5.79e-06	3.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGF—malignant glioma	5.78e-06	3.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTPN11—malignant glioma	5.74e-06	3.85e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CAT—malignant glioma	5.73e-06	3.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.71e-06	3.83e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTEN—malignant glioma	5.68e-06	3.81e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—BCHE—malignant glioma	5.64e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SPHK1—malignant glioma	5.63e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.62e-06	3.77e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC5A5—malignant glioma	5.58e-06	3.74e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTP1—malignant glioma	5.57e-06	3.73e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BCAN—malignant glioma	5.54e-06	3.72e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTEN—malignant glioma	5.53e-06	3.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP2C18—malignant glioma	5.52e-06	3.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—BCHE—malignant glioma	5.52e-06	3.7e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—BRAF—malignant glioma	5.5e-06	3.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTT1—malignant glioma	5.49e-06	3.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CD—malignant glioma	5.48e-06	3.67e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CB—malignant glioma	5.46e-06	3.66e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.46e-06	3.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC5A5—malignant glioma	5.45e-06	3.65e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP2B6—malignant glioma	5.44e-06	3.65e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CAT—malignant glioma	5.42e-06	3.63e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—malignant glioma	5.41e-06	3.63e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NCOR1—malignant glioma	5.41e-06	3.63e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CAV1—malignant glioma	5.41e-06	3.63e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT2—malignant glioma	5.35e-06	3.59e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CD—malignant glioma	5.33e-06	3.57e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.2e-06	3.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.2e-06	3.49e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CA—malignant glioma	5.19e-06	3.48e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.17e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—malignant glioma	5.15e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CD—malignant glioma	5.14e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS1—malignant glioma	5.14e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.12e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NCOR1—malignant glioma	5.11e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—malignant glioma	5.08e-06	3.41e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—malignant glioma	5.06e-06	3.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.02e-06	3.37e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—IDH1—malignant glioma	4.98e-06	3.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—malignant glioma	4.95e-06	3.32e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—malignant glioma	4.94e-06	3.32e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CG—malignant glioma	4.93e-06	3.3e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FGF2—malignant glioma	4.92e-06	3.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTT1—malignant glioma	4.9e-06	3.28e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SPHK1—malignant glioma	4.81e-06	3.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—BCHE—malignant glioma	4.78e-06	3.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CB—malignant glioma	4.78e-06	3.2e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARG—malignant glioma	4.76e-06	3.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.74e-06	3.18e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—malignant glioma	4.73e-06	3.17e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—malignant glioma	4.72e-06	3.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC5A5—malignant glioma	4.72e-06	3.17e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP2C18—malignant glioma	4.72e-06	3.16e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CB—malignant glioma	4.65e-06	3.12e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MDM2—malignant glioma	4.6e-06	3.09e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—malignant glioma	4.6e-06	3.09e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—malignant glioma	4.59e-06	3.08e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RAF1—malignant glioma	4.59e-06	3.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS1—malignant glioma	4.59e-06	3.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.58e-06	3.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.57e-06	3.07e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—malignant glioma	4.54e-06	3.04e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—malignant glioma	4.49e-06	3.01e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTP1—malignant glioma	4.49e-06	3.01e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CB—malignant glioma	4.48e-06	3e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—IDH2—malignant glioma	4.47e-06	2.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTT1—malignant glioma	4.46e-06	2.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.46e-06	2.99e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.45e-06	2.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.42e-06	2.97e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CAV1—malignant glioma	4.41e-06	2.96e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTP1—malignant glioma	4.39e-06	2.94e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CAT—malignant glioma	4.37e-06	2.93e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CD—malignant glioma	4.33e-06	2.9e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—malignant glioma	4.31e-06	2.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CAT—malignant glioma	4.27e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—BCHE—malignant glioma	4.27e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—malignant glioma	4.25e-06	2.85e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—malignant glioma	4.24e-06	2.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC5A5—malignant glioma	4.21e-06	2.83e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.21e-06	2.82e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.2e-06	2.82e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS1—malignant glioma	4.18e-06	2.81e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CAV1—malignant glioma	4.17e-06	2.8e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.17e-06	2.79e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NCOR1—malignant glioma	4.13e-06	2.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—malignant glioma	4.13e-06	2.77e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CASP3—malignant glioma	4.12e-06	2.76e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—malignant glioma	4.11e-06	2.76e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.05e-06	2.72e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NCOR1—malignant glioma	4.03e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—malignant glioma	4.02e-06	2.69e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—malignant glioma	4.01e-06	2.69e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—malignant glioma	4.01e-06	2.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.98e-06	2.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.95e-06	2.65e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.91e-06	2.62e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—malignant glioma	3.9e-06	2.62e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—malignant glioma	3.89e-06	2.61e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—BCHE—malignant glioma	3.89e-06	2.61e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—malignant glioma	3.88e-06	2.6e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—malignant glioma	3.87e-06	2.6e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.86e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC5A5—malignant glioma	3.84e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—IDH1—malignant glioma	3.84e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTT1—malignant glioma	3.81e-06	2.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTP1—malignant glioma	3.8e-06	2.55e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—malignant glioma	3.8e-06	2.55e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CB—malignant glioma	3.78e-06	2.53e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—malignant glioma	3.74e-06	2.51e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SPHK1—malignant glioma	3.72e-06	2.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CAT—malignant glioma	3.7e-06	2.48e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—malignant glioma	3.67e-06	2.46e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.64e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.63e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.6e-06	2.41e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS1—malignant glioma	3.57e-06	2.4e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—malignant glioma	3.57e-06	2.39e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.56e-06	2.39e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CD—malignant glioma	3.53e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—malignant glioma	3.5e-06	2.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NCOR1—malignant glioma	3.49e-06	2.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—malignant glioma	3.46e-06	2.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.44e-06	2.31e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—malignant glioma	3.43e-06	2.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTP1—malignant glioma	3.39e-06	2.28e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CAV1—malignant glioma	3.36e-06	2.26e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CD—malignant glioma	3.34e-06	2.24e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—malignant glioma	3.33e-06	2.23e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—BCHE—malignant glioma	3.32e-06	2.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CAT—malignant glioma	3.3e-06	2.21e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CAV1—malignant glioma	3.29e-06	2.21e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.28e-06	2.2e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—malignant glioma	3.27e-06	2.2e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—malignant glioma	3.26e-06	2.19e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—malignant glioma	3.22e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—malignant glioma	3.19e-06	2.14e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—malignant glioma	3.15e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.14e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NCOR1—malignant glioma	3.12e-06	2.09e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.1e-06	2.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTP1—malignant glioma	3.09e-06	2.07e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CB—malignant glioma	3.08e-06	2.06e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.08e-06	2.06e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—malignant glioma	3.06e-06	2.05e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—malignant glioma	3.05e-06	2.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CAT—malignant glioma	3.01e-06	2.02e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—malignant glioma	3e-06	2.01e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—malignant glioma	2.97e-06	1.99e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—malignant glioma	2.96e-06	1.98e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTT1—malignant glioma	2.94e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—malignant glioma	2.92e-06	1.96e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—malignant glioma	2.91e-06	1.95e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CB—malignant glioma	2.91e-06	1.95e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—malignant glioma	2.89e-06	1.94e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—malignant glioma	2.88e-06	1.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CAV1—malignant glioma	2.85e-06	1.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NCOR1—malignant glioma	2.84e-06	1.91e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—malignant glioma	2.83e-06	1.9e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS1—malignant glioma	2.76e-06	1.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—malignant glioma	2.73e-06	1.83e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.72e-06	1.82e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—malignant glioma	2.72e-06	1.82e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CD—malignant glioma	2.69e-06	1.81e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.68e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—malignant glioma	2.66e-06	1.78e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTP1—malignant glioma	2.64e-06	1.77e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—malignant glioma	2.64e-06	1.77e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.63e-06	1.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.59e-06	1.74e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CAT—malignant glioma	2.57e-06	1.73e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BCHE—malignant glioma	2.56e-06	1.72e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CAV1—malignant glioma	2.54e-06	1.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.53e-06	1.7e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—malignant glioma	2.51e-06	1.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—malignant glioma	2.5e-06	1.68e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NCOR1—malignant glioma	2.43e-06	1.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.43e-06	1.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—malignant glioma	2.38e-06	1.59e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CB—malignant glioma	2.35e-06	1.57e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—malignant glioma	2.33e-06	1.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CAV1—malignant glioma	2.32e-06	1.55e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.32e-06	1.55e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—malignant glioma	2.31e-06	1.55e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—malignant glioma	2.3e-06	1.54e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.3e-06	1.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.28e-06	1.53e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—malignant glioma	2.27e-06	1.52e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—malignant glioma	2.23e-06	1.5e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—malignant glioma	2.23e-06	1.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.21e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.11e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTP1—malignant glioma	2.04e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—malignant glioma	2.04e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.04e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—malignant glioma	2.03e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.99e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CAT—malignant glioma	1.99e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—malignant glioma	1.98e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CAV1—malignant glioma	1.98e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—malignant glioma	1.97e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.89e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—malignant glioma	1.88e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—malignant glioma	1.88e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NCOR1—malignant glioma	1.88e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.86e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.8e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.77e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—malignant glioma	1.77e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—malignant glioma	1.76e-06	1.18e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—malignant glioma	1.74e-06	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—malignant glioma	1.72e-06	1.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.62e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—malignant glioma	1.6e-06	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.59e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—malignant glioma	1.53e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—malignant glioma	1.53e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CAV1—malignant glioma	1.53e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—malignant glioma	1.45e-06	9.72e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—malignant glioma	1.43e-06	9.6e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.4e-06	9.38e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—malignant glioma	1.4e-06	9.37e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.39e-06	9.34e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.38e-06	9.27e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—malignant glioma	1.37e-06	9.19e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—malignant glioma	1.34e-06	9.01e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.22e-06	8.21e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.21e-06	8.13e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—malignant glioma	1.19e-06	8.01e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—malignant glioma	1.17e-06	7.84e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—malignant glioma	1.14e-06	7.66e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.08e-06	7.25e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.07e-06	7.16e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—malignant glioma	1.06e-06	7.09e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—malignant glioma	9.9e-07	6.64e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—malignant glioma	9.86e-07	6.61e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—malignant glioma	9.22e-07	6.18e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—malignant glioma	8.84e-07	5.93e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—malignant glioma	8.43e-07	5.65e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—malignant glioma	8.06e-07	5.4e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—malignant glioma	6.88e-07	4.62e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.5e-07	4.36e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—malignant glioma	5.31e-07	3.56e-06	CbGpPWpGaD
